Mark T. Hegel, PhD
Professor of Psychiatry
Professor of Community and Family Medicine
Professor of The Dartmouth Institute
Community and Family Medicine
The Dartmouth Institute
Georgia State University, Atlanta, GA - PhD 1988
University of Hartford, West Hartford, CT - MA 1982
Assumption College, Worcester, MA - BS 1979
New Hampshire-Dartmouth Psychiatric Research Center
Department of Psychiatry
Dartmouth-Hitchcock Medical Center
Lebanon NH 03756
Behavioral health services in medical patients; Electronic tools for delivery of behavioral health interventions
Principal Investigator: NCI, “Participation Restrictions in Young-Middle Adult Rural Breast Cancer Survivors” (R21CA140849) (4/1/10-3/31/12), $250,000 TDC.
Principal Investigator: Johnson & Johnson, Inc., “Development and Evaluation of Enhanced HealthMedia® OVERCOMING™ Depression to Support Collaborative Depression Treatment in Primary Care: The RESPECT-D-E (Enhanced) Trial” (4/1/10-3/31/13), $689,214 TDC.
Co-Investigator: NINR “Early vs. Later Palliative Cancer Care: Clinical and Biobehavioral Effects”(R01NR011871-01). PI:Marie Bakitas, Dartmouth Medical School (10/1/09-9/30/12).
Consultant: NIMH, “Telehealth Problem Solving Therapy for Depressed Homebound Adults” (R34) PI: Namkee Choi, University of Texas at Austin (4/1/09-3/31/11).
Consultant: NIA, “Improving Care Planning and Well-being in Older Adults with Macular Degeneration” (R01AG00280422). PI: Silvia Sorensen, University of Rochester (7/09-6/14) $1,827,976 TDC
Consultant: NIMH, “Treating Subthreshold Depression in Geriatric Vision Rehabilitation”(R34MH079980). PI: Amy Horowitz, Mt Sinai School of Medicine (9/1/09-8/31/11)
Principal Investigator: Cancer and Leukemia Group B Foundation, “Feasibility of a Phone-Delivered Behavioral Activation/Problem Solving Intervention to Enhance Role Function Recovery and QOL in ‘At-Risk’ Breast Cancer Patients Following Cancer Treatment” (70804) (2008-2010), $25,000 TDC.
Co-Investigator: NEI, “Low Vision Depression Prevention Trial for Age Related Macular Degeneration” (U01 EY018819-01). PI: Barry Rovner, Thomas Jefferson University (1/1/09-12/31/13).
Principal Investigator: NCI, “Preserving Function in Rural Breast Cancer Patients Undergoing Chemotherapy” (1R03CA124200-01) (9/1/06 – 8/31/08).
Principal Investigator: NCI, “Improving Palliative Care for Patients with Cancer” (R01CA101704) (4/1/06-6/30/08).
Co-Investigator: NCI, “Cancer Patients’ Assessments Regarding Excellence (CARE)”. PI: Joan Teno, Brown University (4/1/06-6/30/07).
Co-Investigator: Robert Wood Johnson Foundation Physician Faculty Program, "Managing Depression in Mothers of Head Start Preschoolers". PI: Michael Silverstein, Boston University (1/06-12/10).
Co-Investigator: NEI, “Improving Function in Age Related Macular Degeneration”; PI: Barry Rovner, Thomas Jefferson University (10/05-9/10).
Co-Investigator: NSBRI, “Development of a Smart Medical System for Psychosocial Support During Long Duration Space Flight”; PI: James Carter, Harvard Medical School (1/05-12/07).
Family Practice Clerkship Facilitator (DMS III and IV)
Health, Society and the Physician (DMS IV)
Uncontrolled pilot study of an Acceptance and Commitment Therapy and Health at Every Size intervention for obese, depressed women: Accept Yourself!
Autonomous, Computer-Based Behavioral Health Countermeasure Evaluation at HI-SEAS Mars Analog.
Depression in Visual Impairment Trial (DEPVIT): A Randomized Clinical Trial of Depression Treatments in People With Low Vision.
Cognitive and Affective Representations of Active Surveillance as a Treatment Option for Low-Risk Prostate Cancer.
High Prevalence of Untreated Depression in Patients Accessing Low-Vision Services.
The macular degeneration and aging study: Design and research protocol of a randomized trial for a psychosocial intervention with macular degeneration patients.
Early Versus Delayed Initiation of Concurrent Palliative Oncology Care: Patient Outcomes in the ENABLE III Randomized Controlled Trial.
Benefits of Early Versus Delayed Palliative Care to Informal Family Caregivers of Patients With Advanced Cancer: Outcomes From the ENABLE III Randomized Controlled Trial.
Development and initial evaluation of a telephone-delivered, behavioral activation, and problem-solving treatment program to address functional goals of breast cancer survivors.
Low vision depression prevention trial in age-related macular degeneration: a randomized clinical trial.